Skip to Main Content

Paper Details

HER2-Overexpressing Ductal Carcinoma <i>In Situ</i> Associated with Increased Risk of Ipsilateral Invasive Recurrence, Receptor Discordance with Recurrence.
Cancer Prev Res (Phila)
6
2020
Author NameAffiliation
Sarah L BlairUniversity of California San Diego
Olivier HarismendyMoores Cancer Center and Division of Biomedical Informatics, University of California San Diego
  • 1 - 2

Datasets

Release 1.2